Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1992 Nov;98:125–132. doi: 10.1289/ehp.9298125

Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs.

G Clark 1, A Tritscher 1, D Bell 1, G Lucier 1
PMCID: PMC1519622  PMID: 1336723

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a ubiquitous environmental contaminant that is produced inadvertently during the synthesis of some organochlorine compounds, such as the chlorinated phenoxy pesticides. It is biologically and ecologically persistent, with an estimated half-life of 7 years in humans. It possesses high acute toxicity in rodents and is a carcinogen, teratogen, and immunotoxin. In chronic bioassays for carcinogenicity, TCDD at a dose of 10 ng/kg/day increases the incidence of liver tumors in female rats, making it one of the most potent animal carcinogens ever tested. A recent study in humans has shown an increase in the incidence of respiratory tract tumors in workers in chlorinated phenoxy herbicide plants. Considerable controversy and uncertainty remain, however, concerning its carcinogenic potency in humans and the reliability of using animal data to predict human risks. It is generally accepted that most, if not all, of the effects of TCDD require its binding to the Ah receptor. In addition to its toxic effects, TCDD produces a number of biochemical effects, such as induction of CYP1A1, downregulation of binding activity of the estrogen and epidermal growth factor (EGF) receptors, and changes in cytokine pathways. These effects suggest that the Ah receptor plays an important role in regulating the cell cycle. A number of structural analogs of TCDD, such as the polychlorinated dibenzofurans, also interact with the Ah receptor, and they produce the same spectrum of responses as TCDD in animal and cell models. The potency of these compounds is strongly correlated with their binding affinity to the Ah receptor.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
125

Images in this article

130FIGURE 3.
on p.130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertazzi P. A., Zocchetti C., Pesatori A. C., Guercilena S., Sanarico M., Radice L. Ten-year mortality study of the population involved in the Seveso incident in 1976. Am J Epidemiol. 1989 Jun;129(6):1187–1200. doi: 10.1093/oxfordjournals.aje.a115240. [DOI] [PubMed] [Google Scholar]
  2. Birnbaum L. S., McDonald M. M., Blair P. C., Clark A. M., Harris M. W. Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah Locus. Fundam Appl Toxicol. 1990 Jul;15(1):186–200. doi: 10.1016/0272-0590(90)90175-j. [DOI] [PubMed] [Google Scholar]
  3. Bradfield C. A., Glover E., Poland A. Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse. Mol Pharmacol. 1991 Jan;39(1):13–19. [PubMed] [Google Scholar]
  4. Clark G. C., Blank J. A., Germolec D. R., Luster M. I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression. Mol Pharmacol. 1991 Apr;39(4):495–501. [PubMed] [Google Scholar]
  5. Cook J. C., Dold K. M., Greenlee W. F. An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus. Toxicol Appl Pharmacol. 1987 Jun 30;89(2):256–268. doi: 10.1016/0041-008x(87)90046-9. [DOI] [PubMed] [Google Scholar]
  6. Hoffman E. C., Reyes H., Chu F. F., Sander F., Conley L. H., Brooks B. A., Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science. 1991 May 17;252(5008):954–958. doi: 10.1126/science.1852076. [DOI] [PubMed] [Google Scholar]
  7. Hudson L. G., Shaikh R., Toscano W. A., Jr, Greenlee W. F. Induction of 7-ethoxycoumarin o-deethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. Biochem Biophys Res Commun. 1983 Sep 15;115(2):611–617. doi: 10.1016/s0006-291x(83)80188-0. [DOI] [PubMed] [Google Scholar]
  8. Huff J. E., Salmon A. G., Hooper N. K., Zeise L. Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins. Cell Biol Toxicol. 1991 Jan;7(1):67–94. doi: 10.1007/BF00121331. [DOI] [PubMed] [Google Scholar]
  9. Idle J. R. Is environmental carcinogenesis modulated by host polymorphism? Mutat Res. 1991 Apr;247(2):259–266. doi: 10.1016/0027-5107(91)90021-f. [DOI] [PubMed] [Google Scholar]
  10. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett. 1990 Apr 9;263(1):131–133. doi: 10.1016/0014-5793(90)80721-t. [DOI] [PubMed] [Google Scholar]
  11. Kellermann G., Cantrell E., Shaw C. R. Variations in extent of aryl hydrocarbon hydroxylase induction in cultured human lymphocytes. Cancer Res. 1973 Jul;33(7):1654–1656. [PubMed] [Google Scholar]
  12. Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Dittenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 1978 Nov;46(2):279–303. doi: 10.1016/0041-008x(78)90075-3. [DOI] [PubMed] [Google Scholar]
  13. Kouri R. E., McKinney C. E., Slomiany D. J., Snodgrass D. R., Wray N. P., McLemore T. L. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 1982 Dec;42(12):5030–5037. [PubMed] [Google Scholar]
  14. Kouri R. R., Ratrie H., 3rd, Atlas S. A., Niwa A., Nebert D. W. Aryl hydrocarbon hydroxylase induction in human lymphocyte cultures by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Life Sci. 1974 Nov 1;15(9):1585–1595. doi: 10.1016/0024-3205(74)90324-5. [DOI] [PubMed] [Google Scholar]
  15. Lin F. H., Clark G., Birnbaum L. S., Lucier G. W., Goldstein J. A. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Mol Pharmacol. 1991 Mar;39(3):307–313. [PubMed] [Google Scholar]
  16. Lin F. H., Stohs S. J., Birnbaum L. S., Clark G., Lucier G. W., Goldstein J. A. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol Appl Pharmacol. 1991 Mar 15;108(1):129–139. doi: 10.1016/0041-008x(91)90276-k. [DOI] [PubMed] [Google Scholar]
  17. Lucier G. W., Nelson K. G., Everson R. B., Wong T. K., Philpot R. M., Tiernan T., Taylor M., Sunahara G. I. Placental markers of human exposure to polychlorinated biphenyls and polychlorinated dibenzofurans. Environ Health Perspect. 1987 Dec;76:79–87. doi: 10.1289/ehp.877679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lucier G. W., Tritscher A., Goldsworthy T., Foley J., Clark G., Goldstein J., Maronpot R. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res. 1991 Mar 1;51(5):1391–1397. [PubMed] [Google Scholar]
  19. Luster M. I., Germolec D. R., Clark G., Wiegand G., Rosenthal G. J. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J Immunol. 1988 Feb 1;140(3):928–935. [PubMed] [Google Scholar]
  20. McConnell E. E., Moore J. A., Haseman J. K., Harris M. W. The comparative toxicity of chlorinated dibenzo-p-dioxins in mice and guinea pigs. Toxicol Appl Pharmacol. 1978 May;44(2):335–356. doi: 10.1016/0041-008x(78)90195-3. [DOI] [PubMed] [Google Scholar]
  21. Nagayama J., Kiyohara C., Masuda Y., Kuratsune M. Genetically mediated induction of aryl hydrocarbon hydroxylase activity in human lymphoblastoid cells by polychlorinated dibenzofuran isomers and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol. 1985 Feb;56(4):230–235. doi: 10.1007/BF00295159. [DOI] [PubMed] [Google Scholar]
  22. Neubert R., Jacob-Müller U., Helge H., Stahlmann R., Neubert D. Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 2. In vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on lymphocytes of venous blood from man and a non-human primate (Callithrix jacchus). Arch Toxicol. 1991;65(3):213–219. doi: 10.1007/BF02307311. [DOI] [PubMed] [Google Scholar]
  23. Petersen D. D., McKinney C. E., Ikeya K., Smith H. H., Bale A. E., McBride O. W., Nebert D. W. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet. 1991 Apr;48(4):720–725. [PMC free article] [PubMed] [Google Scholar]
  24. Pitot H. C., Goldsworthy T., Campbell H. A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 1980 Oct;40(10):3616–3620. [PubMed] [Google Scholar]
  25. Poland A., Glover E. 2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus. Mol Pharmacol. 1980 Jan;17(1):86–94. [PubMed] [Google Scholar]
  26. Poland A., Glover E., Ebetino F. H., Kende A. S. Photoaffinity labeling of the Ah receptor. J Biol Chem. 1986 May 15;261(14):6352–6365. [PubMed] [Google Scholar]
  27. Poland A., Knutson J. C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol. 1982;22:517–554. doi: 10.1146/annurev.pa.22.040182.002505. [DOI] [PubMed] [Google Scholar]
  28. Roberts L. Dioxin risks revisited. Science. 1991 Feb 8;251(4994):624–626. doi: 10.1126/science.1846976. [DOI] [PubMed] [Google Scholar]
  29. Silbergeld E. K., Gasiewicz T. A. Dioxins and the Ah receptor. Am J Ind Med. 1989;16(4):455–474. doi: 10.1002/ajim.4700160411. [DOI] [PubMed] [Google Scholar]
  30. Thompson C. L., McCoy Z., Lambert J. M., Andries M. J., Lucier G. W. Relationships among benzo(a)pyrene metabolism, benzo(a)pyrene-diol-epoxide:DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers. Cancer Res. 1989 Dec 1;49(23):6503–6511. [PubMed] [Google Scholar]
  31. Thomsen J. S., Nissen L., Stacey S. N., Hines R. N., Autrup H. Differences in 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in human breast carcinoma cell lines involve altered trans-acting factors. Eur J Biochem. 1991 May 8;197(3):577–582. doi: 10.1111/j.1432-1033.1991.tb15946.x. [DOI] [PubMed] [Google Scholar]
  32. Tucker A. N., Vore S. J., Luster M. I. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol. 1986 Apr;29(4):372–377. [PubMed] [Google Scholar]
  33. Turteltaub K. W., Felton J. S., Gledhill B. L., Vogel J. S., Southon J. R., Caffee M. W., Finkel R. C., Nelson D. E., Proctor I. D., Davis J. C. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5288–5292. doi: 10.1073/pnas.87.14.5288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wahba Z. Z., Lawson T. W., Murray W. J., Stohs S. J. Factors influencing the induction of DNA single strand breaks in rats by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology. 1989 Sep;58(1):57–69. doi: 10.1016/0300-483x(89)90104-2. [DOI] [PubMed] [Google Scholar]
  35. Waithe W. I., Michaud M., Harper P. A., Okey A. B., Anderson A. The Ah receptor, cytochrome P450IA1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem Pharmacol. 1991 Jan 1;41(1):85–92. doi: 10.1016/0006-2952(91)90014-v. [DOI] [PubMed] [Google Scholar]
  36. Wassom J. S., Huff J. E., Loprieno N. A review of the genetic toxicology of chlorinated dibenzo-p-dioxins. Mutat Res. 1977;47(3-4):141–160. doi: 10.1016/0165-1110(77)90001-x. [DOI] [PubMed] [Google Scholar]
  37. Whitlock J. P., Jr Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol. 1990;30:251–277. doi: 10.1146/annurev.pa.30.040190.001343. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES